Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model

Spine

Volumn 36, Issue 3, 2011, Pages

  Lee, Kwang Bok ^a,b   Taghavi, Cyrus E ^a   Song, Kyung Jin ^b   Sintuu, Chananit ^a   Yoo, Jeong Hyun ^a   Keorochana, Gun ^a,c   Tzeng, Shia Tzu ^a,d   Fei, Zhiqiang ^a   Liao, Jen Chung ^a,e   Wang, Jeffrey C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chonbuk National University Medical School   (South Korea)

^c MAHIDOL UNIVERSITY   (Thailand)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ELISA; infl ammation; MIPAV; rhBMP 2; soft tissue edema

Indexed keywords

COLLAGEN SPONGE; INFUSE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FASCIA; GRANULOMA; HEMATOMA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SOFT TISSUE INFLAMMATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOMA; INFLAMMATION; NECK; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; RODENTIA; SEROMA; TRANSFORMING GROWTH FACTOR BETA;

EID: 79551511420     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181f2d1ec     Document Type: Article

References (21)

1. Cloward RB. The anterior approach for removal of ruptured cervical disc. J Neurosurg 1958;15:602-17.
2. Robinson RA, Smith GW. Anterolateral cervical disk removal and interbody fusion for cervical disk syndrome. Bull Johns Hopkins Hosp 1955;96:223-4.
3. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995;20: 1055-60.
4. Boden SB, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81.
5. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337-49.
6. Benglis D, Wang MY, Levi AD. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008;62:ONS423-31.
7. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 2006;31:2813-9.
8. Boakye M, Mummaneni PV, Garrett M, et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2005;2:521-5.
9. Perri B, Cooper M, Lauryssen C, et al. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 2007;7:35-9.
10. Shields LBE, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542-7.
11. Baskin DS, Ryan P, Sonntag V, et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 2003;28:1219-25.
12. Lanman TH, Hopkins TH. Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein 2 was used with poly (L-lactide-co-D, L-lactide) bioabsorbable implants. Neurosurg Focus 2004;16:1-5.
13. Carlisle E, Fischgrund JS. Bone morphogenetic proteins for spinal fusion. Spine J 2005;5:240S-9S.
14. Hochart H, Jenkins PV, Preston RJS, et al. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Thromb Haemost 2008;99:570-5.
15. Foster N, Andreadou K, Jamieson L, et al. VIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BMPa in monocytes. J Den Res 2007;86:883-7.
16. Miyazaki M, Morishita Y, He W, et al. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J 2009;9:22-30.
17. Bazin PL, Cuzzocreo JL, Yassa MA, et al. Volumetric neuroimage analysis extensions for the MIPAV software package. J Neurosci Method 2007;165:111-21.
18. Aube C, Moal F, Oberti F, et al. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci 2007;52:2601-9.
19. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-s with heparin/heparan sulfate is isoformspecific. J Biol Chem 1997;272:18000-6.
20. Rider CC. Heparin/heparan sulphate binding in the TGF- cytokine superfamily. Biochem Soc Transact 2006;34:458-60.
21. Bridwell KH, Anderson PA, Boden SD, et al. What's new in spine surgery? (Specialty Update). J Bone Joint Surg Am 2005;87-A:1892-901.